Healthcare & Medical Investment (TSE:3455) ROCE %: 3.29% (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3455 Healthcare & Medical Investment Corp TSE:3455
59 GF Score
Price 円105,400.00
GF Value 円129,254.71
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Healthcare & Medical Investment ROCE %?

Healthcare & Medical Investment TSE:3455 -2.04% 59 ROCE % is 3.29% as of Jan. 2026. GuruFocus rates TSE:3455 with a GF Score™ of 59/100 and a GF Value™ of 円129,254.71 (Modestly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Healthcare & Medical Investment's annualized ROCE % for the quarter that ended in Jan. 2026 was 3.29%.

Healthcare & Medical Investment  (TSE:3455) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Healthcare & Medical Investment ROCE % Related Terms

Healthcare & Medical Investment ROCE % Historical Data

* Premium members only.

The historical data trend for Healthcare & Medical Investment's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthcare & Medical Investment ROCE % Chart

Healthcare & Medical Investment Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.22 3.42 3.73 3.27 3.17

Healthcare & Medical Investment Semi-Annual Data
Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.33 3.29 3.15 3.21 3.29
TSE:3455
59GF Score
Healthcare & Medical Investment Corp TSE:3455
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healthcare & Medical Investment ROCE % Calculation

Healthcare & Medical Investment's annualized ROCE % for the fiscal year that ended in Jul. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jul. 2025 )  (A: Jul. 2024 )(A: Jul. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jul. 2025 )  (A: Jul. 2024 )(A: Jul. 2025 )
=2427.677/( ( (83456.898 - 6453.629) + (84495.86 - 8404.573) )/ 2 )
=2427.677/( (77003.269+76091.287)/ 2 )
=2427.677/76547.278
=3.17 %

Healthcare & Medical Investment's ROCE % of for the quarter that ended in Jan. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jan. 2026 )  (Q: Jul. 2025 )(Q: Jan. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jan. 2026 )  (Q: Jul. 2025 )(Q: Jan. 2026 )
=2567.876/( ( (84495.86 - 8404.573) + (88786.067 - 8759.266) )/ 2 )
=2567.876/( ( 76091.287 + 80026.801 )/ 2 )
=2567.876/78059.044
=3.29 %

(1) Note: The EBIT data used here is two times the semi-annual (Jan. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 3.29% mean?
Healthcare & Medical Investment (TSE:3455) has a ROCE % of 3.29% as of Jan. 2026.
Is Healthcare & Medical Investment's ROCE % too high?
Healthcare & Medical Investment's current ROCE % is 3.29%. The REITs industry median ROCE % is 5.08. Healthcare & Medical Investment's value of 3.29% is 35.2% below this industry median. Overall, Healthcare & Medical Investment has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthcare & Medical Investment's ROCE % compare to WELL and VTR?
Healthcare & Medical Investment's ROCE % of 3.29% can be compared against companies in the REITs industry. The industry median ROCE % is 5.08. Healthcare & Medical Investment's value of 3.29% is 35.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a REITs company?
The median ROCE % among REITs companies is 5.08, based on 741 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthcare & Medical Investment's current ROCE % of 3.29% is 35.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the REITs industry, the median ROCE % is 5.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthcare & Medical Investment's current ROCE % is 3.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare & Medical Investment stock overvalued right now?
Based on GuruFocus' analysis, Healthcare & Medical Investment (TSE:3455) is currently considered Modestly Undervalued. The stock's GF Value™ is 円129,254.71, compared to a current price of 円105,400.00 — trading 18.5% below its estimated fair value. The current ROCE % is 3.29% and 35.2% below the REITs industry median of 5.08. Healthcare & Medical Investment's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Healthcare & Medical Investment (TSE:3455), the current ROCE % is 3.29% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healthcare & Medical Investment (TSE:3455) Overvalued in 2026?

Based on GuruFocus' analysis, Healthcare & Medical Investment stock appears to be undervalued. The current stock price of 円105,400.00 is trading 18.5% below its estimated GF Value™ of 円129,254.71. GuruFocus considers Healthcare & Medical Investment to be Modestly Undervalued.

Key valuation signals for TSE:3455:

  • ROCE %: 3.29%
  • GF Value™: 円129,254.71 vs. price of 円105,400.00 (18.5% below fair value)
  • GF Score™: 59/100 with 4 warning signs
  • Industry Position: 35.2% below the REITs median

No single metric tells the full story. See the TSE:3455 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healthcare & Medical Investment Business Description

Industry Real EstateREITs
Address 3-3, Kanda-ogawamachi, Chiyoda-ku, Tokyo, JPN
Healthcare & Medical Investment Corp is an investment company, which invests in nursing homes facilities and medical related real properties. The company aims to achieve stable earnings from mid- to long-term perspectives through investment in real estate and other related assets. The firm primarily invests in facilities and buildings for the elderly, as well as medical related facilities.
59GF Score

Get the complete analysis for TSE:3455

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円105,400.00
Price
円129,254.71
GF Value